Funding translational medicine via public markets : the business development company
Year of publication: |
2015
|
---|---|
Authors: | Forman, Sandra M. ; Lo, Andrew W. ; Shilling, Monica ; Sweeney, Grace K. |
Published in: |
Journal of investment management : JOIM. - Lafayette, Calif., ISSN 1545-9144, ZDB-ID 2495180-8. - Vol. 13.2015, 4, p. 9-32
|
Subject: | Business development company | megafund | biotech | pharmaceutical | translational medicine | Drug Royalty Investment Company | intellectual property | royalties | corporate finance | Arzneimittel | Pharmaceuticals | Immaterialgüterrechte | Intellectual property rights | Pharmaindustrie | Pharmaceutical industry | Patent | Unternehmensfinanzierung | Corporate finance |
-
New financing methods in the biopharma industry : a case study of Royalty Pharma, Inc.
Lo, Andrew W., (2014)
-
Fernando, Ruwan, (2023)
-
Prices and related controversies in the biopharmaceutical industry
Manning, Richard L., (2018)
- More ...
-
Global realignment in financial market dynamics: Evidence from ETF networks
Billio, Monica, (2021)
-
Implementing option pricing models when asset returns are predictable
Lo, Andrew W., (1994)
-
A nonparametric approach to pricing and hedging derivative securities via learning networks
Hutchinson, James M., (1994)
- More ...